TITLE

Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies

AUTHOR(S)
Ratcliffe, Elizabeth; Glen, Katie E.; Naing, May Win; Williams, David J.
PUB. DATE
December 2013
SOURCE
British Medical Bulletin;Dec2013, Vol. 108 Issue 1, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Apart from haematopoietic stem cell transplantation for haematological disorders many stem cell-based therapies are experimental. However, with only 12 years between human embryonic stem cell isolation and the first clinical trial, development of stem cell products for regenerative medicine has been rapid and numerous clinical trials have begun to investigate their therapeutic potential. Source of data This review summarizes key clinical trial data, current and future perspectives on stem cell-based products undergoing clinical trials, based on literature search and author research. Areas of agreement It is widely recognized that the ability to stimulate stem cell differentiation into specialized cells for use as cellular therapies will revolutionize health care and offer major hope for numerous diseases for which there are limited or no therapeutic options. Areas of controversy Stem cell-based products are unique and cover a large range of disorders to be treated; therefore, there is significant potential for variation in cell source, type, processing manipulation, the bioprocessing approach and scalability, the cost and purity of manufacture, final product quality and mode of action. As such there are gaps in regulatory and manufacturing frameworks and technologies, only a small number of products are currently within late phase clinical trials and few products have achieved commercialization. Growing points Recent developments are encouraging acceleration through the difficulties encountered en route to clinical trials and commercialization of stem cell therapies. Areas timely for developing research The field is growing year on year with the first clinical trial using induced pluripotent stem cells anticipated by end 2013.
ACCESSION #
92712411

 

Related Articles

  • Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells. Wai Feng Lim; Tomoko Inoue-Yokoo; Keai Sinn Tan; Lai, Mei I.; Daisuke Sugiyama // Stem Cell Research & Therapy;2013, Vol. 4 Issue 3, p1 

    Pluripotent stem cells, both embryonic stem cells and induced pluripotent stem cells, are undifferentiated cells that can self-renew and potentially differentiate into all hematopoietic lineages, such as hematopoietic stem cells (HSCs), hematopoietic progenitor cells and mature hematopoietic...

  • Emerging concepts for the in vitro derivation of murine haematopoietic stem and progenitor cells. Garcia-Alegria, Eva; Menegatti, Sara; Batta, Kiran; Cuvertino, Sara; Florkowska, Magdalena; Kouskoff, Valerie // FEBS Letters;Nov2016, Vol. 590 Issue 22, p4116 

    Well into the second decade of the 21st century, the field of regenerative medicine is bursting with hopes and promises to heal young and old. The bespoken generation of cells is thought to offer unprecedented cures for a vast range of diseases. Haematological disorders have already benefited...

  • Therapeutic potential of stem cells in veterinary practice. Gade, Nitin E.; Pratheesh, M. D.; Nath, Amar; Dubey, Pawan K.; Amarpal; Sharma, G. Taru // Veterinary World;Aug2012, Vol. 5 Issue 8, p499 

    Stem cell research acquired great attention during last decade inspite of incredible therapeutic potential of these cells the ethical controversies exists. Stem cells have enormous uses in animal cloning, drug discovery, gene targeting, transgenic production and regenerative therapy. Stem cells...

  • Emerging Stem Cell Therapies: Treatment, Safety, and Biology. Joel Sng; Thomas Lufkin // Stem Cells International;2012, p1 

    Stem cells are the fundamental building blocks of life and contribute to the genesis and development of all higher organisms. The discovery of adult stem cells has led to an ongoing revolution of therapeutic and regenerative medicine and the proposal of novel therapies for previously terminal...

  • Keeping an eye on stem cells for studying disease modelling and cell-based therapy. Crombie, Duncan // Australasian Biotechnology;Mar2013, Vol. 23 Issue 1, p19 

    The article discusses the use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in treating eye-related diseases. Topics featured in the discussion include regenerative medicine, cell differentiation, and stem cell-based therapy. It mentions the Centre for Eye Research...

  • Advances in MicroRNA-Mediated Reprogramming Technology. Chih-Hao Kuo; Shao-Yao Ying // Stem Cells International;2012, p1 

    The use of somatic cells to generate induced-pluripotent stem cells (iPSCs), which have gene characteristic resembling those of human embryonic stem cells (hESCs), has opened up a new avenue to produce patient-specific stem cells for regenerative medicine. MicroRNAs (miRNAs) have gained much...

  • Modeling hematopoietic transplantation with ES cells  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p353 

    An abstract of the article "Modeling Hematopoietic Transplantation with ES Cells," by George Q. Daley is presented.

  • A Comparison of Stem Cells for Therapeutic Use. Rodgerson, Denis; Harris, Alan // Stem Cell Reviews & Reports;Dec2011, Vol. 7 Issue 4, p782 

    A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent...

  • Senescence suppressors: their practical importance in replicative lifespan extension in stem cells. Hwang, Eun // Cellular & Molecular Life Sciences;Nov2014, Vol. 71 Issue 21, p4207 

    Recent animal and clinical studies report promising results for the therapeutic utilization of stem cells in regenerative medicine. Mesenchymal stem cells (MSCs), with their pluripotent nature, have advantages over embryonic stem cells in terms of their availability and feasibility. However,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics